CHAPERONE-CKMCKM Health Assessment and Patient Empowerment in Chronic Disease using Health Coach Intervention

This clinical trial focuses on the connection between diabetes, heart disease, and kidney disease, often referred to as Cardio Kidney Metabolic (CKM) diseases. These conditions are increasingly common, leading to poor quality of life, premature death, and significant economic burden. The study aims to improve the health of individuals with these chronic diseases using a unique Health Coach Intervention Model. This model is designed to address risk factors such as high blood pressure, high cholesterol, smoking, obesity, unhealthy eating, lack of exercise, and life stressors that contribute to the onset and progression of CKM diseases. The study involves the use of a health coach intervention, known as CHAPERONE AI Treatment. Participants will receive guidance and support to manage their health and reduce the risk of complications. The effectiveness of this treatment will be measured by tracking improvements in patient outcomes. These include the reduction of kidney failure or progression of kidney disease, heart failure, heart attacks, diabetes complications, hospitalizations, and overall mortality rate at 30, 90, and 180 days.